KCC2 is a neuron-specific potassium chloride cotransporter that is important for inhibiting synaptic transmission. Mutations in KCC2 have been linked to disorders such as epilepsy and neuropathic pain. In this Paper of the Week, a team led by Hans Gerd Nothwang at the Carl von Ossietzky University Oldenburg in Germany analyzed six serines on KCC2 from rat neurons that are known to be phosphorylated as well as a threonine residue, which is a putative phosphorylation site. Phosphorylation plays a critical role in regulating the function of KCC2. The investigators demonstrated that phosphorylation of Thr 934 and Ser 937 are major regulators of KCC2's activity. By using pharmacological agents, the investigators found that Thr 934 and Ser 937 , in collaboration with other phosphorylation sites, help the transporter switch between three different conformations with different transport kinetics of ions. "Our data identify a novel key regulatory phosphorylation site of KCC2, and a functional interaction between different conformationchanging post-translational modifications," conclude the authors. "The action of pharmacological agents aimed to modulate KCC2 activity for therapeutic benefit might therefore be highly context-specific." DOI 10.1074/jbc.P114.567834 18680 Ratio of surface signals to total expression signals of KCC2 mutants in HEK-293 cells was measured for each construct.
